Tze-Wen Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tze-Wen Chung has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Shoei-Shen Wang
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan
8 shared publications Der-Zen Liu
3 shared publications- Yu-Chang Tyan
Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3 shared publications Chin‐I Pan
Department of Chemical Engineering, National Yunlin University of Science and Technology, Douliou, Yun‐Lin
2 shared publicationsJean-Dean Yang
2 shared publicationsJui-Hsiang Hsieh
Department of Biomedical Engineering, Chung-Yuan Christian University, Chung-Li 320, Taiwan
2 shared publications
Latest Publications
- 6 March 2013
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (2) , 315-323
Poly (ε-caprolactone) scaffolds functionalized by grafting NGF and GRGD promote growth and differentiation of PC12 cells
- 6 March 2013
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (2) , 315-323
Poly (ε-caprolactone) scaffolds functionalized by grafting NGF and GRGD promote growth and differentiation of PC12 cells
- 12 September 2012
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 23 (12) , 3067-3073
Determining early adhesion of cells on polysaccharides/PCL surfaces by a quartz crystal microbalance
- 12 September 2012
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 23 (12) , 3067-3073
Determining early adhesion of cells on polysaccharides/PCL surfaces by a quartz crystal microbalance
- 21 August 2012
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 137 (21) , 4921-4933
Assessing the responses of cellular proteins induced by hyaluronic acid-modified surfaces utilizing a mass spectrometry-based profiling system: Over-expression of CD36, CD44, CDK9, and PP2A
The cell responses to biopolymer surface at the early adhesion stages can be critical for cell survival. The purpose of this research was to assess formation of hyaluronic acid (HA) biopolymer surface, the fibroblasts were used as an experimental model to evaluate the responses of cellular proteins induced by biopolymer materials using a mass spectrometry-based profiling system. Surfaces were covered by multi-walled carbon nanotubes (CNT), chitosan (CS), and HA to increase the surface area, enhance the adhesion of biopolymer and promote the rate of cell proliferation. The amount of adhered fibroblasts on CNT/CS/HA electrodes of quartz crystal microbalance (QCM) were greatly exceeded those on other surfaces that were consistent with cell-count technique. Moreover, analyzing differential protein expressions of adhered fibroblasts on those biopolymer surfaces by proteomic approaches identified CD36, CD44, PP2A, and CDK9 as key proteins. To validate the influences of those four proteins on adhesions of fibroblasts on biopolymers, the cells were blocked by antibodies of the proteins and the adhesions of cells on the tested biopolymer surfaces were examined using a QCM technique, flow cytometric analysis and morphological observations. The results of significantly decreasing the weights and densities of the blocked fibroblasts adhering to CNT/CS/HA surfaces were obtained, and validate those proteins found by proteomic approaches. Utilizing mass spectrometry-based proteomics to evaluate cell adhesions on biopolymers is proposed.
- 21 August 2012
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 137 (21) , 4921-4933
Assessing the responses of cellular proteins induced by hyaluronic acid-modified surfaces utilizing a mass spectrometry-based profiling system: Over-expression of CD36, CD44, CDK9, and PP2A
The cell responses to biopolymer surface at the early adhesion stages can be critical for cell survival. The purpose of this research was to assess formation of hyaluronic acid (HA) biopolymer surface, the fibroblasts were used as an experimental model to evaluate the responses of cellular proteins induced by biopolymer materials using a mass spectrometry-based profiling system. Surfaces were covered by multi-walled carbon nanotubes (CNT), chitosan (CS), and HA to increase the surface area, enhance the adhesion of biopolymer and promote the rate of cell proliferation. The amount of adhered fibroblasts on CNT/CS/HA electrodes of quartz crystal microbalance (QCM) were greatly exceeded those on other surfaces that were consistent with cell-count technique. Moreover, analyzing differential protein expressions of adhered fibroblasts on those biopolymer surfaces by proteomic approaches identified CD36, CD44, PP2A, and CDK9 as key proteins. To validate the influences of those four proteins on adhesions of fibroblasts on biopolymers, the cells were blocked by antibodies of the proteins and the adhesions of cells on the tested biopolymer surfaces were examined using a QCM technique, flow cytometric analysis and morphological observations. The results of significantly decreasing the weights and densities of the blocked fibroblasts adhering to CNT/CS/HA surfaces were obtained, and validate those proteins found by proteomic approaches. Utilizing mass spectrometry-based proteomics to evaluate cell adhesions on biopolymers is proposed.
- 6 September 2011
- Published by Springer Nature
- p. 185-190
Rat Mesenchymal Cell CD44 Surface Markers: Role in Cardiomyogenic Differentiation
- 6 September 2011
- Published by Springer Nature
- p. 185-190
Rat Mesenchymal Cell CD44 Surface Markers: Role in Cardiomyogenic Differentiation
- Open Access
- 1 January 2011
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 901329
Protein Profiling of Human Nonpigmented Ciliary Epithelium Cell Secretome: The Differentiation Factors Characterization for Retinal Ganglion Cell line
The purpose of this paper was to characterize proteins secreted from the human nonpigmented ciliary epithelial (HNPE) cells, which have differentiated a rat retinal ganglion cell line, RGC‐5. Undifferentiated RGC‐5 cells have been shown to express several marker proteins characteristic of retinal ganglion cells. However, RGC‐5 cells do not respond to N‐methyl‐D aspartate (NMDA), or glutamate. HNPE cells have been shown to secrete numbers of neuropeptides or neuroproteins also found in the aqueous humor, many of which have the ability to influence the activity of neuronal cells. This paper details the profile of HNPE cell‐secreted proteins by proteomic approaches. The experimental results revealed the identification of 132 unique proteins from the HNPE cell‐conditioned SF‐medium. The biological functions of a portion of these identified proteins are involved in cell differentiation. We hypothesized that a differentiation system of HNPE cell‐conditioned SF‐medium with RGC‐5 cells can induce a differentiated phenotype in RGC‐5 cells, with functional characteristics that more closely resemble primary cultures of rat retinal ganglion cells. These proteins may replace harsh chemicals, which are currently used to induce cell differentiation.
- 1 January 2011
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 901329
Open AccessProtein Profiling of Human Nonpigmented Ciliary Epithelium Cell Secretome: The Differentiation Factors Characterization for Retinal Ganglion Cell line
The purpose of this paper was to characterize proteins secreted from the human nonpigmented ciliary epithelial (HNPE) cells, which have differentiated a rat retinal ganglion cell line, RGC‐5. Undifferentiated RGC‐5 cells have been shown to express several marker proteins characteristic of retinal ganglion cells. However, RGC‐5 cells do not respond to N‐methyl‐D aspartate (NMDA), or glutamate. HNPE cells have been shown to secrete numbers of neuropeptides or neuroproteins also found in the aqueous humor, many of which have the ability to influence the activity of neuronal cells. This paper details the profile of HNPE cell‐secreted proteins by proteomic approaches. The experimental results revealed the identification of 132 unique proteins from the HNPE cell‐conditioned SF‐medium. The biological functions of a portion of these identified proteins are involved in cell differentiation. We hypothesized that a differentiation system of HNPE cell‐conditioned SF‐medium with RGC‐5 cells can induce a differentiated phenotype in RGC‐5 cells, with functional characteristics that more closely resemble primary cultures of rat retinal ganglion cells. These proteins may replace harsh chemicals, which are currently used to induce cell differentiation.
- 1 January 2011
- Published by Elsevier in Biomaterials
- Vol. 32 (3) , 734-743
Promoting regeneration of peripheral nerves in-vivo using new PCL-NGF/Tirofiban nerve conduits
- 1 January 2011
- Published by Elsevier in Biomaterials
- Vol. 32 (3) , 734-743
Promoting regeneration of peripheral nerves in-vivo using new PCL-NGF/Tirofiban nerve conduits
- 5 February 2010
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 21 (4) , 1343-1351
Silk fibroin/chitosan–hyaluronic acid versus silk fibroin scaffolds for tissue engineering: promoting cell proliferations in vitro
The feasibility of silk fibroin protein (SF) scaffolds for tissue engineering applications to promote cell proliferation has been demonstrated, as well as the ability to mimic natural extra-cellular matrix (ECM), SF/chitosan (CS), a polysaccharide, scaffolds for tissue engineering. However, the response of cells to SF/CS–hyaluronic acid (SF/CS–HA) scaffolds has not been examined, which this study attempts to do and then compares those results with those of SF scaffolds. SF/CS–HA microparticles were fabricated to produce scaffolds in order to examine the proliferations of human dermal fibroblasts (HDF) in the scaffolds. Positive zeta potentials and ATR-FTIR spectra confirmed the co-existence of SF and CS–HA in SF/CS–HA microparticles. HDF proliferated well and migrated into SF/CS–HA scaffolds for around 160 μm in depth, as well as those in SF scaffolds after 7 days of cultivation, as observed using confocal microscopy. Interestingly, HDF grown in SF/CS–HA scaffolds had a markedly higher cell density than that in SF ones. Additionally, MTT assay revealed that the growth rates of HDF in SF/CS–HA scaffolds significantly exceeded (P < 0.01, n = 5) those in scaffolds of SF and SF/CS. The daily glucose consumptions and lactate formations, metabolic parameters, of HDF grown in SF/CS–HA and SF/CS scaffolds were significantly higher (P < 0.01, n = 3) than those in SF ones in most culturing days. Results of this study suggest that SF/CS–HA scaffolds have better cell responses for tissue engineering applications than SF ones.
- 5 February 2010
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 21 (4) , 1343-1351
Silk fibroin/chitosan–hyaluronic acid versus silk fibroin scaffolds for tissue engineering: promoting cell proliferations in vitro
The feasibility of silk fibroin protein (SF) scaffolds for tissue engineering applications to promote cell proliferation has been demonstrated, as well as the ability to mimic natural extra-cellular matrix (ECM), SF/chitosan (CS), a polysaccharide, scaffolds for tissue engineering. However, the response of cells to SF/CS–hyaluronic acid (SF/CS–HA) scaffolds has not been examined, which this study attempts to do and then compares those results with those of SF scaffolds. SF/CS–HA microparticles were fabricated to produce scaffolds in order to examine the proliferations of human dermal fibroblasts (HDF) in the scaffolds. Positive zeta potentials and ATR-FTIR spectra confirmed the co-existence of SF and CS–HA in SF/CS–HA microparticles. HDF proliferated well and migrated into SF/CS–HA scaffolds for around 160 μm in depth, as well as those in SF scaffolds after 7 days of cultivation, as observed using confocal microscopy. Interestingly, HDF grown in SF/CS–HA scaffolds had a markedly higher cell density than that in SF ones. Additionally, MTT assay revealed that the growth rates of HDF in SF/CS–HA scaffolds significantly exceeded (P < 0.01, n = 5) those in scaffolds of SF and SF/CS. The daily glucose consumptions and lactate formations, metabolic parameters, of HDF grown in SF/CS–HA and SF/CS scaffolds were significantly higher (P < 0.01, n = 3) than those in SF ones in most culturing days. Results of this study suggest that SF/CS–HA scaffolds have better cell responses for tissue engineering applications than SF ones.
- 29 January 2010
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 27 (6) , 514-520
PCP copolymers grafted with RGD enhance the rates of RGD-PCP micelles internalized into cells
RGD-PCP copolymers were fabricated by grafting Arg-Gly-Asp (RGD) peptide to poly(ε-caprolactone)-b-chitooligosaccharide-b–poly(ethylene glycol) (PCP) copolymers and the rate of internalization of RGD-PCP micelles by PC 12 cells were examined. Increasing intensity of the absorbance of amine groups in FT-IR spectra of RGD-PCP copolymers compared with those of PCP copolymers indicated the presence of RGD in new copolymers. Moreover, the grafting efficiency and molar ratio of RGD peptides to PCP copolymers were 88.2% and 0.45, respectively, analysed with HPLC. The RGD-PCP copolymers self-assemble to micelles at the critical micelle concentration (CMC) of 0.018 wt% (178 mg L−1) and with a mean diameter of 90 nm using a dynamic light-scattering (DLS) analyser. Interestingly, the internalization of DPH-loaded RGD-PCP micelles into PC 12 cells is much faster (e.g. within 5 min) than that of PCP micelles. The new RGD-PCP micelles may potentially be used in cellular drug delivery.
- 29 January 2010
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 27 (6) , 514-520
PCP copolymers grafted with RGD enhance the rates of RGD-PCP micelles internalized into cells
RGD-PCP copolymers were fabricated by grafting Arg-Gly-Asp (RGD) peptide to poly(ε-caprolactone)-b-chitooligosaccharide-b–poly(ethylene glycol) (PCP) copolymers and the rate of internalization of RGD-PCP micelles by PC 12 cells were examined. Increasing intensity of the absorbance of amine groups in FT-IR spectra of RGD-PCP copolymers compared with those of PCP copolymers indicated the presence of RGD in new copolymers. Moreover, the grafting efficiency and molar ratio of RGD peptides to PCP copolymers were 88.2% and 0.45, respectively, analysed with HPLC. The RGD-PCP copolymers self-assemble to micelles at the critical micelle concentration (CMC) of 0.018 wt% (178 mg L−1) and with a mean diameter of 90 nm using a dynamic light-scattering (DLS) analyser. Interestingly, the internalization of DPH-loaded RGD-PCP micelles into PC 12 cells is much faster (e.g. within 5 min) than that of PCP micelles. The new RGD-PCP micelles may potentially be used in cellular drug delivery.
- 1 December 2009
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 382 (1-2) , 39-44
Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network
- 1 December 2009
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 382 (1-2) , 39-44
Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network
- 2 December 2008
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 91A (3) , 753-761
The t‐PA‐encapsulated PLGA nanoparticles shelled with CS or CS‐GRGD alter both permeation through and dissolving patterns of blood clots compared with t‐PA solution: An in vitro thrombolysis study
Accelerated thrombolysis by pressure‐driven permeation has been demonstrated in in vitro and in vivo animal models by using plasminogen activators (PAs) encapsulated liposomes or PEG microparticles. Recent reports have also described acceleration of thrombolysis using tissue type PA (t‐PA) encapsulated in PLGA nanoparticles (NPs) coated with chitosan (CS) or CS‐GRGD by interactions between the NPs and blood clots. However, the permeation through and dissolving patterns in thrombolysis with the aforementioned microparticles or NPs, which may be clinically relevant to the recovery status of the posttreatments, have not been reported. Therefore, this work studied such phenomena in thrombolysis with t‐PA encapsulated in NPs. The t‐PA solution and the NPs exhibited distinctly different permeation patterns of dissolved clots. Plasma permeates through clots showed a stream flow or burst flow phenomena when lyzed with NPs shelled with CS or CS‐GRGD, respectively, whereas a diffusion pattern was observed in those lyzed with t‐PA solution. At the outlet position of clots, the clots dissolved with PLGA/CS and PLGA/CS‐GRGD NPs revealed extremely rough surfaces to a depth of 100 μm, indicating that a cross‐permeation direction of clot lysis occurred, while those dissolved with t‐PA solution showed slightly rough surfaces to a depth of 12 μm. Permeation through and clot dissolution patterns of thrombolysis with t‐PA encapsulated in NPs shelled with CS or CS‐GRGD distinctly differed from those dissolved with t‐PA solutions in this in vitro thrombolysis model, These findings may be relevant to posttreatment of patients with conventional PA thrombolysis. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
- 2 December 2008
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 91A (3) , 753-761
The t‐PA‐encapsulated PLGA nanoparticles shelled with CS or CS‐GRGD alter both permeation through and dissolving patterns of blood clots compared with t‐PA solution: An in vitro thrombolysis study
Accelerated thrombolysis by pressure‐driven permeation has been demonstrated in in vitro and in vivo animal models by using plasminogen activators (PAs) encapsulated liposomes or PEG microparticles. Recent reports have also described acceleration of thrombolysis using tissue type PA (t‐PA) encapsulated in PLGA nanoparticles (NPs) coated with chitosan (CS) or CS‐GRGD by interactions between the NPs and blood clots. However, the permeation through and dissolving patterns in thrombolysis with the aforementioned microparticles or NPs, which may be clinically relevant to the recovery status of the posttreatments, have not been reported. Therefore, this work studied such phenomena in thrombolysis with t‐PA encapsulated in NPs. The t‐PA solution and the NPs exhibited distinctly different permeation patterns of dissolved clots. Plasma permeates through clots showed a stream flow or burst flow phenomena when lyzed with NPs shelled with CS or CS‐GRGD, respectively, whereas a diffusion pattern was observed in those lyzed with t‐PA solution. At the outlet position of clots, the clots dissolved with PLGA/CS and PLGA/CS‐GRGD NPs revealed extremely rough surfaces to a depth of 100 μm, indicating that a cross‐permeation direction of clot lysis occurred, while those dissolved with t‐PA solution showed slightly rough surfaces to a depth of 12 μm. Permeation through and clot dissolution patterns of thrombolysis with t‐PA encapsulated in NPs shelled with CS or CS‐GRGD distinctly differed from those dissolved with t‐PA solutions in this in vitro thrombolysis model, These findings may be relevant to posttreatment of patients with conventional PA thrombolysis. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009